Peter Neubert

936 total citations
24 papers, 736 citations indexed

About

Peter Neubert is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Hematology. According to data from OpenAlex, Peter Neubert has authored 24 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Pharmacology and 5 papers in Hematology. Recurrent topics in Peter Neubert's work include Pharmacogenetics and Drug Metabolism (4 papers), Erythropoietin and Anemia Treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Peter Neubert is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Erythropoietin and Anemia Treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Peter Neubert collaborates with scholars based in United States, Germany and United Kingdom. Peter Neubert's co-authors include G. Neugebauer, K. Reiff, E von Möllendorff, W. Akpan, W. Schaumann, B. Kaufmann, Aruna Dharmasena, Manuel Aivado, Ulrich Steidl and Roland Fenk and has published in prestigious journals such as The Lancet, Blood and Journal of Pharmaceutical Sciences.

In The Last Decade

Peter Neubert

22 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Neubert United States 11 230 184 141 87 85 24 736
Toshihiko Uematsu Japan 16 106 0.5× 182 1.0× 113 0.8× 19 0.2× 34 0.4× 49 647
Shin-ichiro Ashida Japan 14 124 0.5× 121 0.7× 202 1.4× 18 0.2× 83 1.0× 27 606
G. Sponer United States 18 94 0.4× 216 1.2× 490 3.5× 24 0.3× 16 0.2× 63 1.0k
Masami Ohmori Japan 14 61 0.3× 110 0.6× 127 0.9× 79 0.9× 33 0.4× 38 558
A. Ocetkiewicz Poland 8 40 0.2× 164 0.9× 190 1.3× 98 1.1× 59 0.7× 13 939
Adriana Menichelli Italy 12 157 0.7× 123 0.7× 60 0.4× 15 0.2× 89 1.0× 35 669
Peter Zannikos United States 19 121 0.5× 215 1.2× 77 0.5× 107 1.2× 25 0.3× 57 1.0k
T. Di Perri Italy 14 36 0.2× 114 0.6× 126 0.9× 37 0.4× 42 0.5× 67 681
Barry Cooper United States 13 132 0.6× 259 1.4× 136 1.0× 21 0.2× 28 0.3× 18 697
Jan‐Arne Björkman Sweden 16 104 0.5× 240 1.3× 522 3.7× 20 0.2× 26 0.3× 38 919

Countries citing papers authored by Peter Neubert

Since Specialization
Citations

This map shows the geographic impact of Peter Neubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Neubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Neubert more than expected).

Fields of papers citing papers by Peter Neubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Neubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Neubert. The network helps show where Peter Neubert may publish in the future.

Co-authorship network of co-authors of Peter Neubert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Neubert. A scholar is included among the top collaborators of Peter Neubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Neubert. Peter Neubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macdougall, Iain C., David E. Roberts, Peter Neubert, et al.. (2015). Pharmacokinetics of Intravenous, Intraperitoneal, and Subcutaneous Recombinant Erythropoietin in Patients on CAPD. Contributions to nephrology. 76. 112–121. 1 indexed citations
2.
Steidl, Ulrich, Simone Bork, Oliver Selbach, et al.. (2004). Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators. Blood. 104(1). 81–88. 97 indexed citations
3.
Steidl, Ulrich, Ralf Kronenwett, Ulrich‐Peter Rohr, et al.. (2002). Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells. Blood. 99(6). 2037–2044. 118 indexed citations
4.
Kientsch-Engel, R., et al.. (1997). No induction of antibodies in patients treated with the recombinant plasminogen activator reteplase (BM 06.022). Fibrinolysis & proteolysis. 11(5-6). 259–264. 1 indexed citations
5.
Kaufmann, B., et al.. (1996). Kinetics of Subcutaneous versus Intravenous Epoetin-Beta in Dogs, Rats and Mice. Pharmacology. 52(5). 329–338. 30 indexed citations
6.
Neugebauer, G. & Peter Neubert. (1991). Metabolism of carvedilol in man. European Journal of Drug Metabolism and Pharmacokinetics. 16(4). 257–260. 50 indexed citations
7.
Bowen, David, et al.. (1991). The clearance of a single i.v. bolus of recombinant human erythropoietin from the serum of patients with myelodysplastic syndromes and its effects on erythropoiesis.. PubMed. 19(7). 613–6. 10 indexed citations
8.
Neubert, Peter, et al.. (1989). PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS. The Lancet. 333(8635). 425–427. 113 indexed citations
9.
Neubert, Peter, et al.. (1989). Automated pre-column high-performance liquid chromatographic method for the investigation of adibendan metabolism. Journal of Chromatography B Biomedical Sciences and Applications. 490(1). 155–164. 2 indexed citations
10.
Neugebauer, G., et al.. (1989). Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.. PubMed. 39(10A). 1339–43. 1 indexed citations
11.
Neubert, Peter, et al.. (1989). Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites.. PubMed. 39(10A). 1317–20. 1 indexed citations
12.
Schaumann, W. & Peter Neubert. (1988). Animal Experiments for Estimating the Radiation Exposure of Human Subjects by Radioactive Drugs. Pharmacology. 37(5). 333–340. 4 indexed citations
13.
Neugebauer, G., W. Akpan, E von Möllendorff, Peter Neubert, & K. Reiff. (1987). Pharmacokinetics and Disposition of Carvedilol in Humans. Journal of Cardiovascular Pharmacology. 10. S85–S88. 71 indexed citations
14.
Neugebauer, G., W. Akpan, E von Möllendorff, Peter Neubert, & K. Reiff. (1987). Pharmacokinetics and Disposition of Carvedilol in Humans. Journal of Cardiovascular Pharmacology. 10. S85–S88. 1 indexed citations
15.
Neugebauer, G., W. Akpan, E von Möllendorff, Peter Neubert, & K. Reiff. (1987). Pharmacokinetics and disposition of carvedilol in humans.. PubMed. 10 Suppl 11. S85–8. 113 indexed citations
16.
Schaumann, W., et al.. (1986). Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. European Journal of Clinical Pharmacology. 30(5). 527–533. 82 indexed citations
17.
Roesch, Erica A., et al.. (1984). [Report of experiences in the treatment of 16 cases of severe glycoside poisoning with digitalis antibody fragments (Fab)].. PubMed. 73(2). 113–9. 14 indexed citations
18.
Neubert, Peter & Klaus Koch. (1977). Simultaneous Automated Determination of Spironolactone Metabolites in Serum. Journal of Pharmaceutical Sciences. 66(8). 1131–1134. 13 indexed citations
19.
Bergmann, Werner & Peter Neubert. (1976). Pflanzendiagnose und Pflanzenanalyse : zur Ermittlung von Ernährungsstörungen und des Ernährungszustandes der Kulturpflanzen. 5 indexed citations
20.
Neubert, Peter. (1968). Polarographische Bestimmung von Chlorat-Rückständen im Boden und in der Pflanze. 4(3). 237–240. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshihiko Uematsu Breakdown of academic impact, for papers by Shin-ichiro Ashida Breakdown of academic impact, for papers by G. Sponer Breakdown of academic impact, for papers by Masami Ohmori Breakdown of academic impact, for papers by A. Ocetkiewicz Breakdown of academic impact, for papers by Adriana Menichelli Breakdown of academic impact, for papers by Peter Zannikos Breakdown of academic impact, for papers by T. Di Perri Breakdown of academic impact, for papers by Barry Cooper Breakdown of academic impact, for papers by Jan‐Arne Björkman
Rankless by CCL
2026